NCT03414268 - Micronized dHACM Injectable for the Treatment of Plantar Fasciitis | Biotech Hunter

Enrollment

208

Participants

Timeline

Start Date

January 8, 2018

Primary Completion Date

March 17, 2021

Study Completion Date

March 17, 2021

Conditions

Fasciitis, Plantar

Interventions

OTHER

Micronized dHACM

1 mL injection of 40 mg Micronized dehydrated human amnion/chorion membrane (dHACM)

DRUG

Saline Injection

Injection of 1mL 0.9% Sodium Chloride Injection, USP

Trial Locations (17)

16602

University Orthopedics Center, Altoona

16801

University Orthopedics Center, State College

21218

Union Podiatry, Baltimore

23464

Coastal Podiatry, Virginia Beach

33143

Doctors Research Network, South Miami

33744

Bay Pines VA Healthcare System, Bay Pines

34232

Gulfcoast Research Institute, LLC, Sarasota

78229

Endeavor Clinical Trials, San Antonio

78501

Futuro Clinical Trials, LLC, McAllen

85723

Southern Arizona VA Health Care System, Tucson

89119

Advanced Foot & Ankle Center, Las Vegas

90057

Foot and Ankle Clinic, Los Angeles

91942

Horizon Clinical Research, La Mesa

92009

ILD Research Center, Carlsbad

93449

Five Cities Foot Clinic, Pismo Beach

93721

Limb Preservation Platform, Inc., Fresno

95608

Center for Clinical Research, Carmichael

All Listed Sponsors

lead

MiMedx Group, Inc.

INDUSTRY